Cargando…
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
On March 11, 2020, the World Health Organization declared the worldwide spread of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as a pandemic. Like in all other infectious diseases, the host immune system plays a key role in our defense against SARS-CoV-2 infect...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270518/ https://www.ncbi.nlm.nih.gov/pubmed/32498686 http://dx.doi.org/10.1186/s12929-020-00663-w |
_version_ | 1783541913194856448 |
---|---|
author | Chang, Feng-Yee Chen, Hsiang-Cheng Chen, Pei-Jer Ho, Mei-Shang Hsieh, Shie-Liang Lin, Jung-Chung Liu, Fu-Tong Sytwu, Huey-Kang |
author_facet | Chang, Feng-Yee Chen, Hsiang-Cheng Chen, Pei-Jer Ho, Mei-Shang Hsieh, Shie-Liang Lin, Jung-Chung Liu, Fu-Tong Sytwu, Huey-Kang |
author_sort | Chang, Feng-Yee |
collection | PubMed |
description | On March 11, 2020, the World Health Organization declared the worldwide spread of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as a pandemic. Like in all other infectious diseases, the host immune system plays a key role in our defense against SARS-CoV-2 infection. However, viruses are able to evade the immune attack and proliferate and, in susceptible individuals, cause severe inflammatory response known as cytokine storm, particularly in the lungs. The advancement in our understanding of the mechanisms underlying the host immune responses promises to facilitate the development of approaches for prevention or treatment of diseases. Components of immune system, such as antibodies, can also be used to develop sensitive and specific diagnostic methods as well as novel therapeutic agents. In this review, we summarize our knowledge about how the host mounts immune responses to infection by SARS-CoV-2. We also describe the diagnostic methods being used for COVID-19 identification and summarize the current status of various therapeutic strategies, including vaccination, being considered for treatment of the disease. |
format | Online Article Text |
id | pubmed-7270518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72705182020-06-04 Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) Chang, Feng-Yee Chen, Hsiang-Cheng Chen, Pei-Jer Ho, Mei-Shang Hsieh, Shie-Liang Lin, Jung-Chung Liu, Fu-Tong Sytwu, Huey-Kang J Biomed Sci Review On March 11, 2020, the World Health Organization declared the worldwide spread of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as a pandemic. Like in all other infectious diseases, the host immune system plays a key role in our defense against SARS-CoV-2 infection. However, viruses are able to evade the immune attack and proliferate and, in susceptible individuals, cause severe inflammatory response known as cytokine storm, particularly in the lungs. The advancement in our understanding of the mechanisms underlying the host immune responses promises to facilitate the development of approaches for prevention or treatment of diseases. Components of immune system, such as antibodies, can also be used to develop sensitive and specific diagnostic methods as well as novel therapeutic agents. In this review, we summarize our knowledge about how the host mounts immune responses to infection by SARS-CoV-2. We also describe the diagnostic methods being used for COVID-19 identification and summarize the current status of various therapeutic strategies, including vaccination, being considered for treatment of the disease. BioMed Central 2020-06-04 /pmc/articles/PMC7270518/ /pubmed/32498686 http://dx.doi.org/10.1186/s12929-020-00663-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Chang, Feng-Yee Chen, Hsiang-Cheng Chen, Pei-Jer Ho, Mei-Shang Hsieh, Shie-Liang Lin, Jung-Chung Liu, Fu-Tong Sytwu, Huey-Kang Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
title | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
title_full | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
title_fullStr | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
title_full_unstemmed | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
title_short | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
title_sort | immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (covid-19) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270518/ https://www.ncbi.nlm.nih.gov/pubmed/32498686 http://dx.doi.org/10.1186/s12929-020-00663-w |
work_keys_str_mv | AT changfengyee immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT chenhsiangcheng immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT chenpeijer immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT homeishang immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT hsiehshieliang immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT linjungchung immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT liufutong immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 AT sytwuhueykang immunologicaspectsofcharacteristicsdiagnosisandtreatmentofcoronavirusdisease2019covid19 |